Request for Nominations for Voting Members on a Public Advisory Committee; Tobacco Products Scientific Advisory Committee (TPSAC)

Issuing agencies

Abstract

The Food and Drug Administration (FDA) is requesting nominations for members to serve on the Tobacco Products Scientific Advisory Committee (TPSAC), in the Center for Tobacco Products. FDA seeks to include the views of qualified individuals on its advisory committees and therefore encourages nominations of appropriately qualified candidates. Specifically, TPSAC is seeking to fill 2 voting member vacancies with physicians, dentists, scientists, or health care professionals practicing in the areas of oncology, pulmonology, cardiology, toxicology, pharmacology, addiction, engineering, or any other relevant specialty.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 198 (Thursday, October 15, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 198 (Thursday, October 15, 2026)]
[Notices]
[Page 65592]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-21027]



[[Page 65592]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2026-N-11624]


Request for Nominations for Voting Members on a Public Advisory 
Committee; Tobacco Products Scientific Advisory Committee (TPSAC)

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for members to serve on the Tobacco Products Scientific 
Advisory Committee (TPSAC), in the Center for Tobacco Products. FDA 
seeks to include the views of qualified individuals on its advisory 
committees and therefore encourages nominations of appropriately 
qualified candidates. Specifically, TPSAC is seeking to fill 2 voting 
member vacancies with physicians, dentists, scientists, or health care 
professionals practicing in the areas of oncology, pulmonology, 
cardiology, toxicology, pharmacology, addiction, engineering, or any 
other relevant specialty.

DATES: Nominations received on or before December 14, 2026 will be 
given first consideration for membership on the TPSAC. Nominations 
received after December 14, 2026 will be considered as later vacancies 
arise.

ADDRESSES: All nominations for membership should be sent electronically 
by logging into the FDA Advisory Committee Nomination Portal at <a href="http://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm">http://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm</a> and select 
``Academician/Practitioner'' as the membership type. Nominations also 
may be submitted by mail to Advisory Committee Oversight and Management 
Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, 
Rm. 3215, Silver Spring, MD 20993-0002. Information about applying for 
membership is available at <a href="https://www.fda.gov/advisory-committees/advisory-committee-membership/applying-membership-fda-advisory-committees">https://www.fda.gov/advisory-committees/advisory-committee-membership/applying-membership-fda-advisory-committees</a>. Information about TPSAC, including committee charter and 
meeting materials, is available at <a href="https://www.fda.gov/advisory-committees/committees-and-meeting-materials/tobacco-products-scientific-advisory-committee">https://www.fda.gov/advisory-committees/committees-and-meeting-materials/tobacco-products-scientific-advisory-committee</a>.
    Nominations submitted to the Request for Nominations for Voting 
Members of Food and Drug Administration Advisory Committees notice 
published on October 1, 2026, will also be considered for the current 
vacancies.

FOR FURTHER INFORMATION CONTACT: 
    Regarding all nomination questions for membership, the primary 
contact is: Advisors and Consultants Staff (ACS), <a href="/cdn-cgi/l/email-protection#6c2f383c41233f412d2f3f2c0a080d4204041f420b031a"><span class="__cf_email__" data-cfemail="125146423f5d413f535141527476733c7a7a613c757d64">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: FDA is requesting nominations for voting 
members on the TPSAC.

I. General Description of Committee Duties

    The Tobacco Products Scientific Advisory Committee (TPSAC or the 
Committee) advises the Commissioner of FDA or designee in discharging 
responsibilities related to the regulation of tobacco products. The 
Committee reviews and evaluates safety, dependence, and health issues 
relating to tobacco products and provides appropriate advice, 
information, and recommendations to the Commissioner of Food and Drugs.
    The Committee may provide recommendations to the Commissioner 
regarding any regulations to be promulgated under Section 917 of the 
Tobacco Control Act (TCA) and may review any applications for new 
tobacco products or petitions for exemption under Section 906(e) of the 
FD&C Act. The Committee may consider and provide recommendations on any 
other matter as provided in the Family Smoking Prevention and Tobacco 
Control Act.

II. Criteria for Voting Members

    The Committee consists of a total of 12 members of whom there are 
nine, technically qualified, voting members including the Chair. 
Members and the Chair are selected by the Commissioner or designee from 
among physicians, dentists, scientists, or health care professionals 
practicing in the areas of oncology, pulmonology, cardiology, 
toxicology, pharmacology, addiction, or any other relevant specialty. 
Members and the Chair are selected from individuals knowledgeable in 
the fields of medicine, medical ethics, science, or technology 
involving the manufacture, evaluation, or use of tobacco products. One 
member shall be an officer or employee of a state or local government 
or of the Federal Government. The final voting member shall be a 
representative of the general public. Almost all non-Federal members of 
this committee serve as Special Government Employees. Members will be 
invited to serve for terms of up to 4 years.

III. Nomination Procedures

    Any interested person may nominate one or more qualified 
individuals for membership on the advisory committee. Self-nominations 
are also accepted. Nominations must include a current, complete 
r[eacute]sum[eacute] or curriculum vitae for each nominee. Nominations 
must also specify the advisory committee for which the nominee is 
recommended. Nominations must also acknowledge that the nominee is 
aware of the nomination unless self-nominated. FDA will ask potential 
candidates to provide detailed information concerning such matters 
related to financial holdings, employment, and research grants and/or 
contracts to permit evaluation of possible sources of conflicts of 
interest.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. 1001) and 21 CFR part 14, relating to advisory committees.

Grace R. Graham,
Deputy Commissioner for Policy, Legislation, and International Affairs.
[FR Doc. 2026-21027 Filed 10-14-26; 8:45 am]
BILLING CODE P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>